News

EFI 2020 postponed

Unfortunately, the EFI 2020 conference has been postponed due to the current COVID-19 pandemic concerns. Another date will be communicated to us soon! Meanwhile, let us know if you have any questions about our Chimerism NGS solutions or any of our other products and we will be happy to answer you. Link to EFI’s commitee …

EFI 2020 postponed Read More »

Today is World Cancer Day

Today is World Cancer Day, as advocated by the Union for International Cancer Control. Their global advocacy for “Treatment For All”, includes 4 important pillars – Improved public health data, early diagnosis, timely treatment, and supportive care.

Cancer overtaking heart disease as leading cause of death

Cancer is overtaking heart disease as the leading cause of death, according to a study published recently in The Lancet medical journal. While heart disease remains the overall leading cause globally, the study of nearly 156k participants, across 21 countries over 11 years, has identified a trend that as living conditions improve, cancer begins to …

Cancer overtaking heart disease as leading cause of death Read More »

On our way to IVDR Compliance

We are very happy to announce that TÜV SÜD has verified the update of our quality management system to the latest revision – ISO13485:2016! This is the first milestone in our compliance and transition from the previous IVD Directive (IVDD) to the newly adopted IVD Regulation (IVDR).

Devyser launches first NGS-based test for mixed chimerism

Swedish molecular diagnostics company Devyser, announced today at the 45th annual European Bone Marrow Transplantation (EBMT) meeting in Frankfurt, Germany, the release of a new NGS-based assay for ultrasensitive and precise measurement of mixed chimerism after Human Stem Cell Transplantation. At EBMT, Devyser presented data obtained with the new Devyser Chimerism assay generated in collaboration …

Devyser launches first NGS-based test for mixed chimerism Read More »

New Whitepaper: Familial Hypercholesterolemia

Devyser is pleased to announce the publication of a new whitepaper Familial Hypercholesterolemia: Genetic Diagnosis and Cascade Testing Using NGS. The 6th in our Expert Review series, this paper is co-authored by Peter Benedek and Kristina Duvefelt, of Karolinska University  Hospital, Stockholm. The paper is a guide to conducting testing using NGS, and the benefits of …

New Whitepaper: Familial Hypercholesterolemia Read More »

Devyser and Dahui Biotech sign distribution deal for the Chinese market

Devyser, pioneer in diagnostic kits for complex DNA testing, and Dahui Biotech, major supplier of biotech and diagnostic products, announce today the signing of a new partnership for distribution of Devyser’s market leading test kits for rapid prenatal aneuploidy diagnostics in China. Ulf Klangby, CEO and founding partner of Devyser, says, “there is an increasing …

Devyser and Dahui Biotech sign distribution deal for the Chinese market Read More »